1. Influence of a Biotechnologically Produced Oyster Mushroom (Pleurotus sajor-caju) on the Gut Microbiota and Microbial Metabolites in Obese Zucker Rats
- Author
-
Erika Most, Robert Ringseis, Klaus Neuhaus, Klaus Eder, Denise K. Gessner, Garima Maheshwari, Holger Zorn, and Publica
- Subjects
0106 biological sciences ,Mushroom ,Oyster ,Pleurotus ,biology ,Prebiotic ,medicine.medical_treatment ,010401 analytical chemistry ,General Chemistry ,Gut flora ,medicine.disease ,biology.organism_classification ,digestive system ,01 natural sciences ,0104 chemical sciences ,biology.animal ,medicine ,Food science ,Steatosis ,Roseburia ,General Agricultural and Biological Sciences ,010606 plant biology & botany ,Bifidobacterium - Abstract
Mushrooms are a rich source of dietary fiber. This study aimed to characterize the modulation of colonic microbiota in Zucker rats after supplementing their diet with a biotechnologically produced oyster mushroom (Pleurotus sajor-caju). Microbiota composition and short chain fatty acids (SCFAs) in the colon and bile acids in the plasma of the rats were analyzed to assess the effects of P. sajor-caju supplementation on the microbiota in the colon and its interplay with the host in the event of hepatic steatosis. Microbiota profiles were distinctly modulated by P. sajor-caju supplementation between the obese control rats and the obese rats fed the 5% P. sajor-caju-supplemented diet. P. sajor-caju enhanced the growth of SCFAs-producing bacterial genera, including Faecalibaculum, Bifidobacterium, Roseburia, and Blautia, and decreased the relative abundance of the pathogenic genus Escherichia-Shigella. This was also accompanied by distinct changes in the concentrations of bile acids in the plasma and concentrations of SCFAs in the colon, supporting the initial potentiality of P. sajor-caju as a prebiotic in cases of hepatic steatosis and liver inflammation.
- Published
- 2021